Eli Lilly (LLY) Removed from Credit Suisse U.S Focus List
Get Alerts LLY Hot Sheet
Price: $726.00 -0.85%
Rating Summary:
25 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 7
Rating Summary:
25 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 7
Join SI Premium – FREE
Credit Suisse removed Eli Lilly (NYSE: LLY) from its U.S Focus List.
The firm maintained an Outperform rating and price target of $87.
For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.
Shares of Eli Lilly closed at $73.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Senate Committee Investigates Ozempic and Wegovy Costs - NYT
- Assa Abloy (ASSAB:SS) (ASAZY) PT Raised to SEK275 at Citi
- Heineken NV (HEIA:NA) (HEINY) PT Raised to EUR77 at RBC Capital
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!